0 Valutazioni

ID

22575

Descrizione

Study ID: 100310 Clinical Study ID: RRL100310 Study Title: A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of intermittent dosing of ropinirole in patients with Restless Legs Syndrome (RLS) Part 22: Visit 3 (Week 5) RLS Episode 10 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00225862 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome More details on: https://clinicaltrials.gov/ct2/show/NCT00225862

collegamento

https://clinicaltrials.gov/ct2/show/NCT00225862

Keywords

  1. 08/06/17 08/06/17 -
  2. 12/06/17 12/06/17 -
Caricato su

8 giugno 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 22: Visit 3 (Week 5) RLS Episode 10

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 22: Visit 3 (Week 5) RLS Episode 10

    General Information
    Descrizione

    General Information

    Subject Identifier
    Descrizione

    Subject Identifier

    Tipo di dati

    text

    PRN Subject Diary
    Descrizione

    PRN Subject Diary

    1. Enter the date and time your RLs symptoms started.
    Descrizione

    Date

    Tipo di dati

    datetime

    2. How severe were your RLS symptoms at the time you took the dose of study medication?
    Descrizione

    Severity of RLS episode

    Tipo di dati

    text

    3. Did your RLS symptoms disrupt your routine evening activity?
    Descrizione

    Did your RLS symptoms disrupt your routine evening activity?

    Tipo di dati

    boolean

    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    Descrizione

    Severity two hours after medication

    Tipo di dati

    text

    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    Descrizione

    Read the following and complete the questions when you wake up next morning.

    Tipo di dati

    text

    6. Overall, did your RLS symptoms affect your sleep last night?
    Descrizione

    Sleep affected by RLS symptoms?

    Tipo di dati

    boolean

    If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
    Descrizione

    Specification of RLS symptoms affecting sleep

    Tipo di dati

    boolean

    Study Medication
    Descrizione

    Study Medication

    Date study medication taken
    Descrizione

    Date study medication taken

    Tipo di dati

    date

    Time study medication taken
    Descrizione

    Time study medication taken

    Tipo di dati

    time

    Similar models

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 22: Visit 3 (Week 5) RLS Episode 10

    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    General Information
    Subject Identifier
    Item
    Subject Identifier
    text
    Item Group
    PRN Subject Diary
    Date
    Item
    1. Enter the date and time your RLs symptoms started.
    datetime
    Item
    2. How severe were your RLS symptoms at the time you took the dose of study medication?
    text
    Code List
    2. How severe were your RLS symptoms at the time you took the dose of study medication?
    CL Item
    mild (1)
    CL Item
    moderate (2)
    CL Item
    severe (3)
    CL Item
    very severe (4)
    Did your RLS symptoms disrupt your routine evening activity?
    Item
    3. Did your RLS symptoms disrupt your routine evening activity?
    boolean
    Item
    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    text
    Code List
    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    CL Item
    I was asleep at 2 hours after taking the last dose  (1)
    CL Item
    None (2)
    CL Item
    Mild (3)
    CL Item
    Moderate (4)
    CL Item
    Severe (5)
    CL Item
    Very Severe (6)
    Item
    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    text
    Code List
    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    CL Item
    Very much improved (Complete symptom relief) (1)
    CL Item
    Much improved (Good symptom relief) (2)
    CL Item
    Minimally improved (Some symptom relief) (3)
    CL Item
    No change (4)
    CL Item
    Minimally worse (Symptoms minimally worse) (5)
    CL Item
    Much worse (Symptoms much worse) (6)
    CL Item
    Very much worse (Symptoms very much worse) (7)
    Sleep affected by RLS symptoms?
    Item
    6. Overall, did your RLS symptoms affect your sleep last night?
    boolean
    Specification of RLS symptoms affecting sleep
    Item
    If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
    boolean
    Item Group
    Study Medication
    Date study medication taken
    Item
    Date study medication taken
    date
    Time study medication taken
    Item
    Time study medication taken
    time

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial